ABSTRACT. The antibody response to the recombinant protein, R32tet32, which contained the repetitive sequence (NANP) n of Plasmodium falciparum CSP was determined in C57BL/6 mice during the course of nonlethal infection with Plasmodium yoelii 17X. Marked suppression of the IgG antibody response to R32tet32 occurred when mice were immunized at peak parasitemia (on day 16). In vitro antibody responses of spleen cells from acutely infected mice to R32tet32 were similarly suppressed. Stimulation of normal spleen cells cultured for 5 days with 100 ng/ml of R32tet32 gave an optimal IgG antibody response, but spleen cells from infected mice obtained at peak parasitemia failed to respond to a broad range of antigen concentrations. Cocultivation studies employing enriched lymphocyte populations from infected and uninfected C57BL/6 mice indicated that both T and B cells from infected mice were defective in their response to R32tet32. The response to the repetitive region was restored by the addition of recombinant mouse interleukin-2 (IL-2) at a dose of 50 U/ml to cultures of spleen cells from infected mice.
Defective immune response has been known to be associated with both human malaria and experimental malaria [1, 9-11, 17, 18] . During the course of nonlethal infection with Plasmodium yoelii 17X, primary antibody response to heterologous erythrocytes such as horse and sheep erythrocytes is markedly suppressed. We and others have demonstrated that the splenic macrophages of the malarious mice were functionally defective as accessory cells in antibody response to horse and sheep erythrocytes [1, 11, 17, 18] . On the other hand, Grillot et al. [4] reported that mice immunized with repetitive region of P. falciparum circumsporozoite (CS) protein, (NANP) 40 , also showed suppressed antibody responses to the synthetic peptide during P. yoelii malaria infection. However, the mechanisms responsible for the suppression induced by P. yoelii malaria remain to be determined. R32tet32 is a recombinant protein which contains the repetitive epitope, (NANP) n , of the P. falciparum CS protein. In the present study, we examined whether in vitro antibody response to the recombinant antigen, R32tet32, was also suppressed during P. yoelii malaria infection. Furthermore, by using the recombinant protein and the in vitro antibody formation system, cell populations which had involved in the suppression of antibody response to the repetitive sequence were determined.
MATERIALS AND METHODS

Animals:
Male C57BL/6 mice were purchased from The Jackson Laboratory (Bar Harbor, ME) and maintained in the AALAC (American Association for Accreditation of Laboratory Animal Care) approved animal facility. Periodically, serum samples from sentinel animals were screened to confirm that the colony was free of viral pathogens. All animals were used at 6 to 10 wk of age.
Parasites and infection: LDH virus free, nonlethal isolates of Plasmodium yoelii yoelii 17X (P. yoelii 17X) were stored as a frozen stabilate in a liquid nitrogen freezer. Parasites were obtained as a gift from Dr. John Finnerty (NIH, Bethesda, MD), and subsequently cloned by limiting dilution in our laboratory. The stabilate material was used to initiate infection in a donor mouse which was subsequently bled as a source for parasitized erythrocytes. Experimental infections were initiated with parasitized erythrocytes obtained from a donor animal infected with stabilate material. The determination of parasitemia of infected mice was assessed through the microscopic examination of Giemsa stained smears of tail blood. Percent parasitemia was calculated as follows: [(no. infected erythrocytes)/(total no. erythrocytes counted)] × 100 = %parasitemia.
Antigens: Circumsporozoite (CS) antigens, R32tet32 {[(NANP) 15 NVDP] 2 Tet1-32} and R32LAK {[(NANP) 15 NVDP] 2 LAK} were the generous gift of Drs. Mitchell Gross and James Young of Smith Kline Beechum. R32tet32 is a recombinant protein comprised of 32 tandem tetrapeptide repeats derived from the circumsporozoite (CS) protein of the 7G8 strain of Plasmodium falciparum fused to the first 32 amino acids of the tetracycline resistance gene read out of frame [19] . The recombinant protein, R32LAK, is a truncated version of R32tet32 containing the repeat region and three additional amino acids. NANP is designated the major repeat, NVDP designated the minor repeat. R32tet32, which had shown the strong immunogenicity, was used for immunization and R32LAK was used as captured antigen for ELISA to detect the repeat-region specific antibody responses.
Immunization: Mice were immunized intraperitoneally with 50 µg of R32tet32 in sterile phosphate buffered saline (PBS), pH 7.2. Antibody responses to the peptide in the sera were determined 7 days after immunization. Spleen-cell preparation: Infected or normal mice were sacrificed by cervical dislocation and their spleens were placed into 5 ml of Hanks' balanced salt solutions (HBSS). Single cell suspensions were prepared by gently teasing spleens with rat-toothed forceps. After centrifugation, the red blood cells were lysed by hypotonic shock and cells were washed in cold HBSS. Membrane debris was removed by filtering the cell suspension through sterile nylon mesh. The cells were then resuspended to a final concentration of 5 × 10 6 cells/ml in RPMI 1640 medium (Gibco, Grand Island, NY) supplemented with 10% heat-inactivated fetal calf serum (FCS), 20 mM HEPES buffer, 5 × 10 -5 M 2-mercaptoethanol, 2.0 mM L-glutamine, 100 U/ml penicillin, and 100 µg/ml streptomycin (R-10S).
Cell separation: To get the lymphocyte population, whole spleen cell suspension was fractionated with FicollPaque, and subsequently, the lymphocyte fraction was incubated in the petri dishes (100 × 15 mm) at 37°C for two hours to deplete macrophage thoroughly. T lymphocyteenriched population was obtained by passage of the resulting plastic nonadherent cells through nylon wool columns as described by Julius et al. [7] . To further enrich the B-lymphocyte population, nylon wool adherent cells were harvested and treated with cytotoxic anti-T cocktail (antiThy1.2, anti-CD4 and anti-CD8 antibodies) and low toxic rabbit complement (Cederlane Lab. Ltd., Ontario, Canada). Each preparation was referred to as T-or B-enriched cell populations.
Enzyme-Linked Immunosorbent Assay (ELISA) for the detection of specific antibody to the repetitive sequence:
For the detection of antibody specific for the repeat region of the CS protein, Immulon II 96 well microtiter plates (Nunc, Roskilde, Denmark) were coated with R32LAK (2 µg/ml, 50 µl/well) diluted with 0.1 M carbonate/bicarbonate buffer, pH 9.6, and incubated overnight at 4°C. The plates were then washed with tris buffered saline including 0.1% Tween 20 (0.1% TBS-Tween). Wells were then "blocked" with 200 µl of 1% TBS-Tween for 1 hr at room temperature. After washing the plates, 50 µl of samples was added to the wells and incubated overnight at 4°C. Plates were washed and 50 µl of a biotinylated goat anti-mouse heavy chain Ig antisera (Zymed, San Francisco, CA) diluted 1:500 in 0.1% TBS-Tween was added for 1 hr at room temperature. The plates were washed and 50 µl of avidine-alkaline phosphatase diluted 1:1,000 in 0.1% TBS-Tween was added. After 1 hr at room temperature, the plates were washed thoroughly and the substrate solution (200 µl) was added. The plates were then incubated at 37°C in the dark. The reaction was stopped by the addition of 30 µl of 5 N NaOH. The substrate was prepared in a buffer of 10 mM ZnCl 2 , 10 mM MgCl 2 -6H 2 O and 1 M glycine, pH 10.4. The buffer was prewarmed to 37°C and Sigma 104 phosphatase substrate (Sigma Chemical Co., St Louis, MO) was added at a concentration of 2 mg/ml. The absorbance of individual wells was determined using a Titertek Plate Reader Set at a wavelength of 404 nm.
RESULTS
In vivo antibody responses to R32tet32 during P. yoelii 17X infection: C57BL/6 mice infected with the nonlethal variant of P. yoelii 17X exhibited a course of infection characterized by a moderate peak parasitemia occurring between days 14-16 after infection (Fig. 1) . After that, there was a rapid decrease in parasitemia to subpatent levels and parasites were cleared by 3-4 weeks after infection. At various periods after infection (on days 6, 16, 29, and 51) (arrows in Fig. 1 ), five mice each were immunized with 50 µg of R32tet32 without adjuvant and the primary antibody response to the antigen was determined on day 7 after each immunization. As shown in Fig. 2 , suppression of the IgG antibody response to R32tet32 began to occur from early in infection (day 6) and peaked when mice were immunized with the antigen at peak parasitemia (day 16). The capability to produce specific antibodies in mice immunized with R32tet32 on day 51 after infection was comparable to that in uninfected normal mice although it was relatively low in mice immunized on day 29 after infection.
In vitro antibody responses to R32tet32 by spleen cells from mice infected with P. yoelii 17X:
To examine whether in vitro antibody responses are also suppressed by malaria infection, spleen cells were collected from normal mice or mice infected with P. yoelii on day 16 after infection and cultured with R32tet32. Preliminary experiments had shown that the optimal concentration of R32tet32 for normal spleen cells to produce specific antibody was 100 ng/ml (data not shown). As shown in Fig. 3 , normal spleen cells stimulated with 100 ng/ml R32tet32 produced significantly high levels of IgG antibody from 3-day culture, but spleen cells from P. yoelii-infected mice failed to produce the specific antibody even after 5-day cultivation with optimized antigen concentrations.
Anti-R32tet32 antibody responses in spleen cell culture containing nonadherent and adherent cells from normal or infected mice: To identify the defective cell population in P. yoelii-infected mice, spleen cells were fractionated into macrophage-rich adherent cells and lymphocyte-rich nonadherent cells (Fig. 4) . When nonadherent spleen cells from normal mice (N.NA) were combined with adherent spleen cells from infected mice (I.A), the IgG antibody response to R32tet32 was reconstituted ( Fig.4; N. NA +I.A). Conversely, when nonadherent spleen cells from infected mice (I.NA) were combined with adherent spleen cells from normal mice (N.A), the response to R32tet32 was markedly depressed (Fig. 4; I.NA +N.A) . Suppresser cell activity was not evident because cultures containing spleen cells from infected and normal mice showed similar responses obtained by cultures containing 50% spleen cells from normal mice alone (data not shown). These results indicated that nonadherent cells but not adherent cells in the spleen of P. yoelii-infected mice were defective for antibody production to R32tet32.
Anti-R32tet32 antibody responses in spleen cell culture containing T-enriched and B-enriched cell populations from normal or infected mice:
Next, in order to identify the defective cells in nonadherent splenic cells from infected mice, they were further fractionated into T-enriched and Benriched cell populations and cultured with normal Tenriched and B-enriched cells, respectively. Each culture contained the adherent cells from normal spleen cells. As shown in Fig. 5 , IgG antibody producing capability of the Benriched cell population from infected mice (I.B) was not restored by the addition of T-enriched cell population from normal mice (N.T). Moreover, T-enriched cell population from the spleens of infected mice (I.T) failed to restore the antibody-producing capability of B-enriched cell population from normal mice (N.B). These cocultivation studies employing enriched lymphocyte populations from infected and uninfected C57BL/6 mice indicated that both T and B cells from infected mice were defective in their response to R32tet32.
Effect of recombinant IL-2 on antibody responses to R32tet32 in spleen cells:
In an array of cytokines, the ability of spleen cells to produce IL-2 has been shown to be markedly reduced during P. yoelii-malaria infection [9, 10] . To examine if the lack of IL-2 was involved in the defective antibody-forming capability of spleen cells from infected mice, recombinant IL-2 was added to the culture and the levels of specific antibody were determined. Figure 6 showed that IgG antibody response to R32tet32 was restored by the addition of recombinant IL-2 at a dose of 50 U/ml to cultures. These results suggest that T lymphocytes from mice infected with P. yoelii do recognize epitope(s) on R32tet32, but may fail to produce sufficient IL-2 for helper function in the antibody response to the antigen. 
DISCUSSION
Suppression and recovery of immune responses were observed in primary antibody responses to R32tet32, which contained immunodominant B cell epitope (NANP) n in the repeat region of P. falciparum CS protein, in C57BL/6 mice infected with a nonlethal strain of P. yoelii. Grillot et al. [4] reported that mice immunized with synthetic peptide, (NANP) 40 , emulsified with complete Freund's adjuvant also showed suppressed antibody responses to the peptide during P. yoelii malaria infection. In their experiment, however, immunization of the synthetic peptide was carried out only once during infection and the mice were periodically examined for antibody response after that. In the present study, we decided not to use adjuvant for immunization in order to apply the results obtained from the in vivo experiments for further in vitro experiment. Moreover, mice were immunized with R32tet32 at each period of time (ascending, descending and convalescent periods) instead of only once immunization after inoculation of the parasites to avoid the modification of immune response during infection. In spite of different protocol, the suppression of antibody responses to the repetitive sequence occurred in mice infected with P. yoelii and we confirmed that mice immunized with R32tet32 at peak parasitemia (day 16) induced drastic suppression of anti-(NANP) n IgG responses.
The results of the present study demonstrated that the in vitro antibody responses of spleen cells from acutely infected mice to (NANP) n were similarly suppressed. As their responses reflected the results of the in vivo experiments, the mechanism involved in defective antibody production to (NANP) n was studied by using the in vitro spleen cell culture system. From previous studies with horse erythrocytes (HRBC), it appeared that adherent spleen cells, presumably splenic macrophages, from P. yoelii-infected mice were unable to take up HRBC, suggesting that the functional R32tet32. Spleen cells from mice infected with P. yoelii were prepared on day 16 after parasite inoculation and cultured with 100 ng of R32tet32 (Ag+) or without antigens (Ag-) for 2-5 days. IgG levels were determined in supernatants by ELISA. Data represent mean values ± SD for triplicate cultures.
defect was at the level of antigen uptake [17] . In the present study, we showed that the adherent spleen cells from infected mice could support the antibody formation of nonadherent cells from normal mice, demonstrating that the initial steps of antibody production to (NANP) n , antigen processing and presentation probably proceed normally in acute phase of P. yoelii-infection. In contrast, the suppressed antibody responses to (NANP) n of infected mouse spleen cells appear to be caused by a loss in activity of some of nonadherent cells. Although the responses to both the particulate (SRBC and HRBC) and soluble [(NANP) n ] antigens were suppressed during this malaria, immune responses to different antigens may be suppressed by the different mechanisms.
The diminished T-cell responses and a defect in the production of IL-2 have been observed during the acute stage of infection with P. falciparum [6, 16] and P. yoelii [9] . Moreover, Lucas et al. [10] reported that the transcript for IL-2 was not detected in mice with acute P. yoelii malaria although mRNA for the cytokine was detectable late in the infection when mice cleared the parasites. In the present study, we showed that the antibody response to (NANP) n was restored by the addition of recombinant mouse IL-2 to cultures of spleen cells from acutely infected mice. These results may suggest that 1) B lymphocytes have a potency to produce antibodies to (NANP) n if they get appropriate signals, 2) T/B lymphocytes from mice infected with P. yoelii do recognize (NANP) n , but may fail to produce sufficient IL-2 for helper function in the antibody response to (NANP) n .
We found that T cells from spleens of normal mice failed to restore the antibody-producing capability of B cells from infected mice to normal levels. The nature of this deficit remains to be determined. One may speculate that another possible mechanism might also be involved in the defective antibody responses to (NANP) n during this malaria. IL-10 was described as a cytokine primarily produced by the Th2 subset of CD4 + T lymphocytes [3] and Ly-1 + B lymphocytes [12] that inhibited the synthesis of several cytokines includ- ing IL-2 by the Th1 subset [2] . Some findings indicate that IL-10 production was induced by parasite infections including Trypanosoma cruzi [14] , Leishmania major [5] and Schistosoma mansoni [13] . It is conceivable that B cells from spleens of P. yoelii-infected mice secret some factors such as IL-10 and inhibit T cells from normal spleen cells. However, we found that high levels of IL-10 production were induced by lethal but not nonlethal variant of P. yoelii, although B cells may be involved in the IL-10 response during the nonlethal infection [8] . The possibility that IL-2 was not sufficient does also seem likely. IL-2 is produced by B cells as well as T cells. Splenic B cells from normal mice have been reported to contain IL-2 mRNA [5] and produce IL-2 when cultured with mitogens [15] . Therefore, B cells from infected mice might not produce sufficient IL-2 for help themselves to produce antibodies. These possibilities are under investigation. Further studies aimed at characterizing the cytokines from T-cell and B-cell subset in the spleen of infected mice will provide the information how soluble antigens like this peptide evade the immunodepression during malaria. 
